Location History:
- Redondo Beach, CA (US) (2022)
- Manhattan Beach, CA (US) (2020 - 2023)
- Los Angeles, CA (US) (2023)
Company Filing History:
Years Active: 2020-2023
Title: Luis Rodriguez-Borlado: A Pioneering Inventor in Ocular and Muscular Treatment Innovations
Introduction
Luis Rodriguez-Borlado, based in Manhattan Beach, California, is an innovative inventor known for his contributions to the fields of ocular health and muscular therapy. With a total of four patents to his name, Rodriguez-Borlado has made significant strides in developing methods for treating complex medical conditions through advanced cellular technologies.
Latest Patents
His latest patents include groundbreaking methodologies aimed at enhancing treatment for ocular inflammation and chemical injuries of the eye using extracellular vesicles. One notable innovation focuses on providing a method for treating chemical injuries, specifically alkali burns of the cornea, and conditions such as ocular graft-versus-host disease (GVHD). This invention introduces a formulation comprising extracellular vesicles derived from human cardiosphere-derived cells for effective administration to the eye.
Another recent patent addresses the treatment of skeletal muscular dystrophy, including Duchenne muscular dystrophy (DMD). This method involves delivering cardiosphere-derived cells (CDCs) directly to dystrophic skeletal muscles through intramuscular or systemic injection. Additionally, it includes the innovative use of noncoding RNAs found in CDC-derived exosomes to enhance dystrophin protein levels within heart and skeletal muscles, thereby improving exercise capabilities for DMD patients.
Career Highlights
Throughout his career, Rodriguez-Borlado has worked with esteemed organizations such as Capricor, Inc. and Cedars-Sinai Medical Center. His work has been integral in pushing the boundaries of current medical treatments, harnessing the potential of cellular therapies to address previously challenging health issues.
Collaborations
Rodriguez-Borlado's journey has also been marked by fruitful collaborations. Notable colleagues include Houman Hemmati and Kiel A. Peck, with whom he has likely shared insights and research to further enhance the innovations within his field.
Conclusion
Luis Rodriguez-Borlado exemplifies the spirit of innovation in the medical sector, particularly concerning ocular and muscular health. His patents not only contribute to advancing treatment methods but also reflect a broader commitment to improving patient outcomes through scientific exploration and collaboration. The impact of his work is anticipated to resonate within the fields of medicine for years to come.